Smoking adversely influences comorbidities in rheumatoid arthritis (RA). The aim of this pilot study was to investigate whether smoking cessation is increased following a 3-month smoking cessation intervention tailored for people with RA.
39 current smokers with RA were recruited. Participants were randomized to receive the current local standard of care for smoking cessation (ABC: brief advice and subsidised nicotine replacement therapy) (control), or ABC+ additional smoking cessation advice for 3 months including face-to-face, telephone and email contact (intervention). Advice was tailored to participants' specific needs from a range of intervention tools focused on education about smoking and RA, pain control, exercise, coping, and support. The primary outcome was smoking cessation at 6 months. The secondary outcome was sustained reduction in smoking at 6 months. Disease and psychosocial characteristics of quitters and non-quitters were examined.
The overall smoking cessation rate was 24%. There was no significant difference in smoking cessation rates between the ABC and ABC+ groups (21% vs 26%; P=0.70). The mean number of cigarettes smoked daily reduced by 44% (P<0.001) but did not differ between ABC and ABC+ groups (mean reduction 47% vs 41%; P=0.72). Successful quitters had more years in education and had smoked less across their lifetime, but these differences were not statistically significant.
Smoking cessation in RA may lead to a reduced comorbid burden. The lack of added benefit of the tailored intervention suggests brief advice and NRT currently the best practice supporting people with RA who wish to quit smoking. This article is protected by copyright. All rights reserved.
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2016.
All research outputs
#3,619,874
of 27,536,871 outputs
Outputs from Arthritis Care & Research
#1,211
of 3,189 outputs
Outputs of similar age
#48,853
of 283,164 outputs
Outputs of similar age from Arthritis Care & Research
#22
of 52 outputs
Altmetric has tracked 27,536,871 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,189 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.9. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 283,164 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
